AMY SPOON: Open Payments
NPI 1487137147 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 38 payments from 10 companies in 2025. Trend: 2023 $1,083 · 2024 $1,483 · 2025 $1,363
Food & beverage: $956Travel & lodging: $405Education: $1
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 11 | $878 |
| Novo Nordisk Inc | 6 | $115 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Alnylam Pharmaceuticals Inc. | 4 | $71 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| VivaQuant Inc, dba Rhythm Express | 1 | $7 |
Products named: SAPIEN 3 Ultra RESILIA, Wegovy, ELIQUIS, AMVUTTRA, LEQVIO, VERQUVO, LifeVest, WAINUA.
Industry payments across VA — which companies pay providers there.
